Diabetes.co.uk is excited to announce that our award-winning Low Carb Program has received CE Mark approval, meaning it is now registered with the Medicines & Healthcare products Regulatory Agency (MHRA).
In being awarded CE Mark approval, the Low Carb Program conforms to European Union laws as a registered medical device meeting all of the MHRA’s health and safety regulations.
Charlotte Summers, Chief Operating Officer of Diabetes.co.uk, said: “We are delighted to receive CE Mark approval. For over two years the Low Carb Program has been showing that type 2 diabetes does not have been be a chronic or progression disease; this approval provides additional quality assurance needed to scale out the Low Carb Program and support even more people with type 2 diabetes.”
Low Carb Program completers achieve an average HbA1c reduction of 13 mmol/mol (1.2%), and also lose 7% of their body weight. Additionally, the Low Carb Program has shown to be hugely cost-effective, saving the NHS £835 per person, per year in prescription costs.
